Royal Philips is showcasing its integrated radiation oncology solutions in the exhibition at the European Society for Radiation Oncology’s (ESTRO) 37th Annual Meeting in Barcelona, Spain.
Focused on enhancing precision therapy delivery, optimizing radiation dose management and reducing time to treatment, Philips’ dedicated radiation oncology solutions help deliver more accurate, comprehensive treatment plans.
In addition, Philips is announcing a collaboration with Sun Nuclear to integrate its suite of PlanIQ™ software with Philips’ Pinnacle3 16.2 Auto-Planning to aid clinicians in establishing feasible treatment goals.
Philips radiation oncology general manager Ardie Ermers said: “Today’s radiation oncology treatment planning processes are still fragmented, labor-intensive and time-consuming, potentially producing inconsistent results and delaying the start of treatment.
“Creating a patient-specific treatment plan that is designed around a robust assessment of the patient is essential. By integrating innovative tools, systems and software, Philips helps improve care delivery, time-to-treatment and overall patient satisfaction.”
To further its mission in radiation oncology treatment planning, Philips is collaborating with Sun Nuclear to integrate its suite of PlanIQ™ software with Pinnacle3 16.2 Auto-Planning.
Based on each patient’s own anatomy, PlanIQ uses unique, patented technology to provide the clinician with achievable, patient-specific goals for the treatment plan. Integrated with Pinnacle3 Auto-Planning, a personalized treatment plan can be created more efficiently.
Sun Nuclear CEO Jeff Simon said: “We are pleased to partner with Philips to bring the powerful capabilities of PlanIQ to the Pinnacle3 user community.”
At the exhibition at this year’s ESTRO conference, Philips is highlighting a portfolio of solutions to help enable a confident path to treatment focused on the key areas of imaging and simulation, treatment planning, and tumor follow-up and response.
Source: Company Press Release